Allelic variation in
HLA‐DRB1
is associated with development of a
ntidrug
antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro
Clinical and Translational Science(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要